Literature DB >> 8872869

Cholecystokinin peptides and receptor binding in Alzheimer's disease.

C Löfberg1, J Harro, C G Gottfries, L Oreland.   

Abstract

Cholecystokinin (CCK) is a peptide that can be found in the cerebral cortex in high concentrations and is involved in learning and memory as well as neurodegenerative processes. Cortical brain samples from 9 patients with Alzheimer's disease and 9 matched control cases were studied with respect to the concentrations of various molecular forms of CCK and the CCK receptor binding characteristics. No differences were found between patients and controls in any of these measures. Significant correlations were found between the concentrations of CCK-8 sulphated and the three nonsulphated CCK peptides measured. In addition, the concentrations of CCK-4 and CCK-5 showed a highly significant and positive correlation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8872869     DOI: 10.1007/BF01273363

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  22 in total

1.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

2.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

3.  Cholecystokinin and somatostatin in Alzheimer's disease postmortem cerebral cortex.

Authors:  M F Mazurek; M F Beal
Journal:  Neurology       Date:  1991-05       Impact factor: 9.910

Review 4.  Peptidergic modulation of learning and memory processes.

Authors:  G L Kovács; D De Wied
Journal:  Pharmacol Rev       Date:  1994-09       Impact factor: 25.468

Review 5.  CCK in animal and human research on anxiety.

Authors:  J Harro; E Vasar; J Bradwejn
Journal:  Trends Pharmacol Sci       Date:  1993-06       Impact factor: 14.819

6.  Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes.

Authors:  E K Perry; G Blessed; B E Tomlinson; R H Perry; T J Crow; A J Cross; G J Dockray; R Dimaline; A Arregui
Journal:  Neurobiol Aging       Date:  1981       Impact factor: 4.673

7.  Two brain cholecystokinin receptors: implications for behavioral actions.

Authors:  T H Moran; P H Robinson; M S Goldrich; P R McHugh
Journal:  Brain Res       Date:  1986-01-01       Impact factor: 3.252

8.  Radioimmunoassay of cholecystokinin: comparison of different tracers.

Authors:  P Cantor; J F Rehfeld
Journal:  J Immunol Methods       Date:  1985-09-03       Impact factor: 2.303

Review 9.  The role of CCK caerulein, and CCK antagonists in nociception.

Authors:  Nigel Scott Baber; Colin Trevor Dourish; David Robert Hill
Journal:  Pain       Date:  1989-12       Impact factor: 6.961

10.  Prevalence of dementia disorders in institutionalized Swedish old people. The work load imposed by caring for these patients.

Authors:  R Adolfsson; C G Gottfries; L Nyström; B Winblad
Journal:  Acta Psychiatr Scand       Date:  1981-03       Impact factor: 6.392

View more
  5 in total

1.  Cholecystokinin and Alzheimer's disease: a biomarker of metabolic function, neural integrity, and cognitive performance.

Authors:  Alexandra Plagman; Siobhan Hoscheidt; Kelsey E McLimans; Brandon Klinedinst; Colleen Pappas; Vellareddy Anantharam; Anumantha Kanthasamy; Auriel A Willette
Journal:  Neurobiol Aging       Date:  2019-01-09       Impact factor: 4.673

2.  Effect of cholecystokinin on experimental neuronal aging.

Authors:  Xiao-Jiang Sun; Qin-Chi Lu; Yan Cai
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

Review 3.  Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review.

Authors:  Bart Stragier; Dimitri De Bundel; Sophie Sarre; Ilse Smolders; Georges Vauquelin; Alain Dupont; Yvette Michotte; Patrick Vanderheyden
Journal:  Heart Fail Rev       Date:  2007-11-08       Impact factor: 4.214

4.  Cholecystokinin peptides and receptors in the rat brain during stress.

Authors:  J Harro; C Löfberg; J F Rehfeld; L Oreland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-06       Impact factor: 3.000

5.  Cholecystokinin octapeptide improves hippocampal glutamatergic synaptogenesis and postoperative cognition by inhibiting induction of A1 reactive astrocytes in aged mice.

Authors:  Lei Chen; Ning Yang; Yue Li; Yitong Li; Jingshu Hong; Qian Wang; Kaixi Liu; Dengyang Han; Yongzheng Han; Xinning Mi; Chengmei Shi; Ying Zhou; Zhengqian Li; Taotao Liu; Xiangyang Guo
Journal:  CNS Neurosci Ther       Date:  2021-08-17       Impact factor: 5.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.